• Fenipentol Workflows for GI Secretion Research

  2026-09-03

  Fenipentol offers a defined small-molecule approach to secretory and hepatobiliary assays, with practical value for measuring pancreatic fluid, lipase, and bicarbonate-linked responses. This guide combines formulation guidance, assay controls, isomer-aware interpretation, and troubleshooting for reproducible gastrointestinal physiology studies.

• ATRX Loss and RTK Inhibitor Sensitivity in Glioma

  2026-09-03

  Pladevall-Morera et al. identified a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells showed greater sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient comparators. The study also found pronounced toxicity when RTK inhibition was combined with temozolomide, supporting ATRX status as an important variable in glioma drug studies rather than establishing a single validated treatment.

• FPH1 (BRD-6125) Hepatocyte Workflow Guide

  2026-09-02

  FPH1 (BRD-6125) helps build more renewable, function-focused hepatocyte models by pairing proliferation readouts with albumin, CYP3A4, and AFP measurements. This guide explains how to dose the compound, distinguish expansion from maturation, and evaluate its fit alongside emerging light-regulated gene-expression workflows.

• Topotecan Pharmacology and Clinical Evidence

  2026-09-02

  The 1999 review by Kollmannsberger and colleagues presents topotecan as a water-soluble camptothecin analogue that stabilizes the DNA–topoisomerase I cleavage complex, linking molecular pharmacology with early clinical evidence. Its analysis clarifies how lactone stability, renal elimination, schedule, hematologic toxicity, and tumor type shaped the development of topotecan and its potential combinations.

• Annexin V-Cy5/DAPI Apoptosis Kit Guide

  2026-09-01

  The Annexin V-Cy5/DAPI Apoptosis Kit converts phosphatidylserine exposure and membrane integrity into a practical map of cell-death states. This guide applies that two-parameter logic to P2RX1-driven mitochondrial apoptosis and tyrosine kinase inhibitor response in Ph+ ALL.

• FPH1 (BRD-6125): Function-First Liver Translation

  2026-09-01

  A thought-leadership guide to using FPH1 (BRD-6125) as a function-first tool for hepatocyte expansion, iPSC-derived hepatocyte workflows, and translational model development—while distinguishing established product evidence from forward-looking integration with controllable gene regulation.

• Ampicillin Sodium: From Selection to Translation

  2026-08-31

  Ampicillin sodium is more than a routine plasmid-selection reagent. Its transpeptidase-directed mechanism connects recombinant protein workflows, antibacterial activity assays, antibiotic resistance research, and bacterial infection models. This thought-leadership guide shows how translational teams can use the compound strategically while separating literature-backed parameters from workflow recommendations and avoiding overinterpretation of research-only data.

• LG 101506: A Causal RXR Assay Framework

  2026-08-30

  LG 101506 is an RXR modulator suited to mechanistic studies of nuclear receptor signaling. This article presents a causal assay framework linking RXR perturbation with PD-L1 stability, glycosylation, and immune-response measurements without overstating untested therapeutic effects.

• Septin4, VHL, and HIF-1α in Hypoxic Cardiomyocytes

  2026-08-29

  The reference study identifies Septin4 as a previously unrecognized aggravator of hypoxia-induced cardiomyocyte injury and connects this effect to VHL-dependent ubiquitination and degradation of HIF-1α. Its cell-based results suggest that preserving HIF-1α stability may be cardioprotective, while also defining important limits for translating this mechanism into pharmacological or renal anemia research.

• Clozapine N-oxide (CNO) and Circuit Translation

  2026-08-29

  Clozapine N-oxide (CNO) offers translational researchers a controllable route from engineered GPCR signaling to cell-type-specific neuronal activity modulation. This article connects CNO-enabled chemogenetics with recent evidence for subtype-specific somatostatin interneuron plasticity and outlines a rigorous strategy for causal circuit studies.

• RSL3 and GPX4: Translating Ferroptosis Biology

  2026-08-28

  RSL3 offers a direct way to interrogate GPX4 dependency, ferroptosis, and redox vulnerabilities. This thought-leadership guide connects RSL3 research with radioresistance, local angiotensin II signaling, biomarker strategy, and translational decision-making while maintaining clear preclinical boundaries.

• Isoproterenol Sulfate Dihydrate in SAN Research

  2026-08-28

  Isoproterenol sulfate dihydrate is a non-selective beta-adrenergic agonist for controlled studies of GPCR signaling, cardiac rate responses, and cAMP/PKA pathway activation. Its defined hemisulfate dihydrate formulation, high reported purity, and water and DMSO solubility support reproducible cardiovascular research workflows when acute pharmacology is separated from slower pacemaker maturation.

• Tetrandrine: Applied Assay Workflows

  2026-08-27

  Tetrandrine is a DMSO-soluble natural-product probe for connecting calcium signaling, membrane transport, inflammation, and cell-state phenotypes. This workflow-first guide shows how to design concentration ranges, control solvent effects, validate ion channel modulation, and interpret structure-based screening without overstating antiviral evidence.

• 5-Azacytidine Triggers DNA Damage in Myeloma

  2026-08-27

  The reference study shows that 5-Azacytidine produces more than DNA hypomethylation in multiple myeloma cells: it activates an ATR-dominated double-strand break response and engages both caspase-dependent and caspase-independent apoptosis. Its combination with doxorubicin or bortezomib produced synergistic cytotoxicity, providing a mechanistic basis for combination-oriented multiple myeloma research.

• TCAIM Control of OGDH and Mitochondrial Metabolism

  2026-08-26

  Wang and colleagues identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds OGDH and lowers its protein abundance through an HSPA9–LONP1-dependent process. The study reveals that mitochondrial proteostasis can directly tune α-ketoglutarate dehydrogenase complex activity and carbohydrate catabolism, extending chaperone biology beyond conventional protein folding.

454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page